Use of Methylene Blue to Treat Vasoplegia Syndrome in Cystic Fibrosis Patients Undergoing Lung Transplantation: A Case Series

BACKGROUND: Several studies have demonstrated the utility of methylene blue (MB) to treat vasoplegic syndrome (VS), but some have cautioned against its routine use in lung transplantation with only two cases described in prominent literature. Cystic fibrosis patients commonly have chronic infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Washington, Gabriel C., O’Donnell, Christian T., Madhok, Jai, Williams, Kiah M., Hill, Charles C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997460/
https://www.ncbi.nlm.nih.gov/pubmed/36722586
http://dx.doi.org/10.4103/aca.aca_276_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997460/
https://www.ncbi.nlm.nih.gov/pubmed/36722586
http://dx.doi.org/10.4103/aca.aca_276_20

Ejemplares similares